BioSpace News Archive

Business

Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health

Medicines360, a global nonprofit pharmaceutical organization specializing in women’s health, announced the appointment of Lisa David as Chair of the Board of Directors, effective January 1, 2024.

January 24, 2024
·
2 min read
Circular Genomics Raises $8.3 Million for Debut of Circular RNA Assay in Precision Psychiatry

Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the closing of an $8.3 Million Series A investment round.

January 24, 2024
·
3 min read
BioMidwest

Applied Nanoscience Inc. Commissions U.S.-based Pilot Plant and Unveils Strategic IP Sale Process

Applied Nanoscience Inc. disclosed that a newly constructed pilot plant has been commissioned to ensure reliable production scale-up of the company’s groundbreaking NanoFense technology.

January 24, 2024
·
2 min read
Pharm Country

New Tool Reveals Gene Behavior in Bacteria

Bacterial infections cause millions of deaths each year, with the global threat made worse by the increasing resistance of the microbes to antibiotic treatments.

January 24, 2024
·
4 min read
Pharm Country

Enhatch Announces FDA Clearance for a TKA Patient Specific Instrumentation System with AI-Assisted Segmentation and Treatment Planning

Enhatch Inc. is excited to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance of a patient specific instrumentation system for Total Knee Arthroplasty.

January 24, 2024
·
3 min read
Verisense Health Launches Research-Grade Smart Watch, Smashing Previous Price/Performance Benchmarks

Verisense Health combined its wearable technology expertise and clinical research knowledge to satisfy this unmet market need.

January 24, 2024
·
3 min read
Business

Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024

Avantor, Inc. announced that it will release its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February, 14, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Standard Time.

January 24, 2024
·
1 min read
Drug Development

Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis

Sionna Therapeutics today announced that the first healthy subject has been dosed in a Phase 1 clinical trial of SION-109 following clearance of its Investigational New Drug application (IND) by the U.S. Food and Drug Administration (FDA).

January 24, 2024
·
2 min read
Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®

Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.

January 24, 2024
·
3 min read
Lone Star Bio

Babson Diagnostics Recognized for Achieving Highest Standards of Quality and Patient Safety for Laboratory Medicine

Babson Diagnostics today announced its new, highly automated microsample laboratory has been awarded accreditation by the College of American Pathologists (CAP) based on the results of a recent on-site inspection.

January 24, 2024
·
4 min read